The abstract is read at the publisher; the summary is JClub's.
Xelari enables de novo DNA and RNA aptamer design from protein structures without target-specific SELEX data, achieving InNA RMSE 0.19 kcal/mol across 483,735 reference pairs.
- Why it matters: SELEX-based aptamer discovery can be limited by target availability, selection biases, and the need for optimization or retraining. A structure-driven alternative is needed to reduce these constraints.
- What they did: Xelari uses modular algorithmic steps plus surrogate models trained on physical or structural references, including InNA, AliNA, Edgar, and ValentiNA. InNA reproduced nucleotide–amino-acid interaction energies with RMSE 0.19 kcal/mol across 483,735 reference pairs.
- The result: In a treponeme assay, three DNA aptamers designed from Treponema pallidum protein structures showed cell-associated binding with apparent K D of 0.91–2.57 μM. A fourth DNA aptamer functioned as a capture reagent in a serum-based hybrid aptamer-antibody assay for Tau441.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.